BACKGROUND Human papillomavirus (HPV) is the most common sexually transmitted infection in the US and the oropharynx is the most common site of HPV-associated cancer. The FDA’s approval for the nonavalent HPV vaccine expanded in 2020 to include prevention of oral cancers. Oral health practitioners (OHPs) are uniquely situated to recommend HPV vaccination as a primary preventive measure for oropharyngeal cancer (OPC). The aim of the project was to equip dental providers to educate patients about HPV and its link to OPC and to make a strong recommendation for vaccination. Patients could attain…